相关实验视频

Updated: Aug 6, 2026

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

在人类多能干细胞中开发一种菌病毒CRISPR/Cas9载体系统,用于β-2-微球蛋白淘汰

Zaiying Xiang¹, Qiaoyuan Ye², Zihan Zhao¹

¹Department of Biology, College of Science, Shantou University, Shantou, Guangdong, China.

Molecular genetics and genomics : MGG

|July 31, 2024

概括

研究人员开发了一种细菌病毒CRISPR/Cas9系统,以破坏人类干细胞中的β-2-微型球蛋白 (B2M) 基因,从而产生用于移植的低免疫细胞.

科学领域:

干细胞生物学干细胞生物学
基因编辑基因编辑
免疫学免疫学免疫学

背景情况:

来自多能干细胞的低免疫细胞对移植医学至关重要.
破坏β-2-微球蛋白 (B2M) 基因是制造这些细胞的关键策略.
克里斯普尔/Cas9和baculovirus提供高效的基因编辑能力.

研究的目的:

开发一种菌病毒CRISPR/Cas9载体,用于在人体细胞中向B2M基因破坏.
评估B2M破坏细胞的低免疫性潜力.
为了证实改造干细胞的多能性和分化能力.

主要方法:

开发一种细菌病毒CRISPR/Cas9系统.
在人类胚胎干细胞 (hESC) 中用于B2M基因编辑的应用.
人类白细胞抗原I类表达的评估.
与人类外周血液单核细胞共同培养测定,使用衍生纤维细胞.
通过Elispot测试评估所有免疫反应.

主要成果:

在hESC中成功地实现了B2M基因淘汰/淘汰.
观察到人类白细胞抗原I类表达的稳定下调.
衍生性纤维细胞显示显著减少了所有免疫反应.
B2M负的hESC保留了多能性和差异化潜力.

结论:

细菌病毒-CRISPR/Cas9系统有效地创造了B2M破坏的多能干细胞.
B2M 干扰导致适合全原细胞疗法的低免疫细胞.
这种方法支持开发用于移植的通用捐赠细胞.

关键词:

细菌病毒病毒的病毒.这就是CRISPR/Cas9的作用.低免疫性细胞是一种细胞.多能干细胞是多能干细胞.这是一种β-2-微型血球蛋白.

更多相关视频

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

Published on: November 1, 2024

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...